Cargando…
Calcimimetics Alter Periosteal and Perilacunar Bone Matrix Composition and Material Properties in Early Chronic Kidney Disease
Chronic kidney disease (CKD) affects 15% of Americans and greatly increases fracture risk due to elevated parathyroid hormone, cortical porosity, and reduced bone material quality. Calcimimetic drugs are used to lower parathyroid hormone (PTH) in CKD patients, but their impact on bone matrix propert...
Autores principales: | Damrath, John G., Moe, Sharon M., Wallace, Joseph M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283238/ https://www.ncbi.nlm.nih.gov/pubmed/35593150 http://dx.doi.org/10.1002/jbmr.4574 |
Ejemplares similares
-
Osteocyte Remodeling of the Perilacunar and Pericanalicular Matrix
por: Qing, Hai, et al.
Publicado: (2009) -
Non‐Additive Effects of Combined NOX1/4 Inhibition and Calcimimetic Treatment on a Rat Model of Chronic Kidney Disease‐Mineral and Bone Disorder (CKD‐MBD)
por: Damrath, John G, et al.
Publicado: (2022) -
Control of Bone Matrix Properties by Osteocytes
por: Creecy, Amy, et al.
Publicado: (2021) -
Multimodal X-ray imaging of nanocontainer-treated macrophages and calcium distribution in the perilacunar bone matrix
por: Stachnik, Karolina, et al.
Publicado: (2020) -
Glucocorticoids cause mandibular bone fragility and suppress osteocyte perilacunar-canalicular remodeling
por: Alemi, A. Sean, et al.
Publicado: (2018)